Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (JAGX) on October 28, 2020. The Company is an emerging growth company incorporated in Delaware and trades on The Nasdaq Capital Market. The report addresses a critical regulatory event regarding the Company's continued listing status.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing compliance event rather than financial performance results.
Material Changes and Events
- Nasdaq Listing Extension: On October 28, 2020, the Nasdaq Hearings Panel granted the Company an extension through December 23, 2020, to demonstrate compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)).
- Compliance Requirement: To maintain listing, the Company must achieve a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days by the December 23, 2020 deadline.
- Delisting Risk: The Company had previously been notified by the Listing Qualifications Staff that it no longer satisfied the minimum bid price rule and was subject to delisting. A hearing held on October 22, 2020, resulted in the granted extension.
Outlook, Risks, and Management Commentary
Management plans to take steps to timely evidence compliance with the minimum bid price requirement; however, the Company explicitly states there can be no assurance that it will be able to do so. The filing contains forward-looking statements regarding these intentions, warning that actual results may differ materially. Investors are directed to the Company's 2019 Form 10-K for detailed risk factors.
Investor Verification Checklist
- Verify the Company's daily closing bid price to monitor progress toward the $1.00 threshold.
- Confirm whether the Company achieves ten consecutive trading days above $1.00 before the December 23, 2020 deadline.
- Review the Company's 2019 Form 10-K for comprehensive risk factors related to delisting and financial condition.
- Monitor for any subsequent 8-K filings regarding the outcome of the compliance period or potential delisting notices.